Macronix International Bilan de santé

Santé financière contrôle des critères 3/6

Macronix International possède un total de capitaux propres de NT$45.6B et une dette totale de NT$24.3B, ce qui porte son ratio d'endettement à 53.3%. Son actif total et son passif total sont NT$78.8B et de NT$33.2B.

Informations clés

53.3%

Ratio d'endettement

NT$24.29b

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	NT$10.22b
Fonds propres	NT$45.60b
Total du passif	NT$33.23b
Total des actifs	NT$78.83b

Mises à jour récentes de la santé financière

Is Macronix International (TWSE:2337) A Risky Investment?

Jul 19

Does Macronix International (TPE:2337) Have A Healthy Balance Sheet?

Mar 22

Recent updates

Macronix International Co., Ltd.'s (TWSE:2337) Share Price Is Matching Sentiment Around Its Revenues

Oct 28

Macronix International Co., Ltd. (TWSE:2337) Analysts Are Pretty Bullish On The Stock After Recent Results

Aug 04

Is Macronix International (TWSE:2337) A Risky Investment?

Jul 19

Macronix International's (TWSE:2337) Dividend Will Be Reduced To NT$0.50

Jun 13

Macronix International Co., Ltd.'s (TWSE:2337) Business And Shares Still Trailing The Industry

Jun 04

Is Macronix International Co., Ltd. (TPE:2337) The Right Choice For A Smart Dividend Investor?

Apr 11

Does Macronix International (TPE:2337) Have A Healthy Balance Sheet?

Mar 22

Will Macronix International's (TPE:2337) Growth In ROCE Persist?

Mar 06

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 2337 ( NT$29.6B ) dépassent ses passifs à court terme ( NT$10.4B ).

Passif à long terme: Les actifs à court terme de 2337 ( NT$29.6B ) dépassent ses passifs à long terme ( NT$22.9B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 2337 ( 30.9% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de 2337 est passé de 47.1% à 53.3% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de 2337 est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de 2337 sur sa dette sont bien couverts par l'EBIT.

Macronix International Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Is Macronix International (TWSE:2337) A Risky Investment?

Does Macronix International (TPE:2337) Have A Healthy Balance Sheet?

Recent updates

Third quarter 2024 earnings: EPS misses analyst expectations

Macronix International Co., Ltd. announced that it expects to receive TWD 3 billion in funding

Macronix International Co., Ltd.'s (TWSE:2337) Share Price Is Matching Sentiment Around Its Revenues

Macronix International Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Macronix International Co., Ltd. (TWSE:2337) Analysts Are Pretty Bullish On The Stock After Recent Results

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates upgraded to NT$1.21 loss

Macronix International Co., Ltd. Announces Nomination Committee Changes

Is Macronix International (TWSE:2337) A Risky Investment?

Macronix International Co., Ltd. to Report Q2, 2024 Results on Jul 30, 2024

Macronix International's (TWSE:2337) Dividend Will Be Reduced To NT$0.50

Dividend of NT$0.50 announced

Macronix International Co., Ltd.'s (TWSE:2337) Business And Shares Still Trailing The Industry

Macronix International Co., Ltd. Announces the Resignation of Cheng-Wen Wu as Independent Director

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 27%

Macronix Non-Volatile Memory Solutions Showcase with Partners NXP, ST at Embedded World 2024

Macronix International Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Macronix International Co., Ltd., Annual General Meeting, May 30, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates have been downgraded.

Macronix International Co., Ltd. to Report Q4, 2023 Results on Jan 30, 2024

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.9% to NT$32.17

Consensus EPS estimates have been downgraded.

Macronix International Co., Ltd. to Report Q3, 2023 Results on Oct 24, 2023

Consensus EPS estimates fall by 27%

Consensus EPS estimates fall by 27%

New major risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: NT$0.04 (vs NT$1.59 in 2Q 2022)

Consensus EPS estimates fall by 17%

Macronix International Co., Ltd. to Report Q2, 2023 Results on Jul 25, 2023

Macronix International Co., Ltd. to Report Q2, 2023 Results on Jul 25, 2023

Upcoming dividend of NT$1.80 per share at 5.5% yield

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 22%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased by 14% to NT$36.75

Macronix International Co., Ltd. to Report Q4, 2022 Results on Feb 14, 2023

Macronix International Co., Ltd. Announces the Replacement of Chief Information Security Officer

Consensus EPS estimates fall by 14%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Macronix International Co., Ltd. Appoints Y. H. Chao as Chief Information Security Officer

Price target decreased to NT$42.52

Macronix International Announces its octaflash MX66UW1G45GXDI00

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Macronix International Co., Ltd. to Report Q2, 2022 Results on Jul 26, 2022

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$1.80 per share

Macronix octaflash UW Series Memory Provides High-Density Flash Solutions for NXP S32Z and S32E Real-Time Processors

Macronix International Co., Ltd. Appoints Cheng-Wen Wu to its Nomination Committee

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Less than half of directors are independent

Macronix International Co., Ltd. to Report Q1, 2022 Results on Apr 26, 2022

Macronix International Co., Ltd. announced a financing transaction

Macronix International Co., Ltd., Annual General Meeting, May 27, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Now 21% undervalued

Macronix International Co., Ltd. Announces to Bring 120MHz 1.2V Serial NOR Flash Memories to Mass Production

Third quarter 2021 earnings released: EPS NT$2.94 (vs NT$0.88 in 3Q 2020)

Upcoming dividend of NT$1.20 per share

Hon Hai Precision Industry Co., Ltd. (TWSE:2317) agreed to acquire Semiconductor Manufacturing Facility in Hsinchu Science Park from Macronix International Co., Ltd. (TWSE:2337) for TWD 2.5 billion.

Consensus EPS estimates increase to NT$4.37

Second quarter 2021 earnings released: EPS NT$1.04 (vs NT$0.72 in 2Q 2020)

Investor sentiment deteriorated over the past week

Consensus revenue estimates increase to NT$47.8b

Price target increased to NT$54.05

First quarter 2021 earnings released: EPS NT$0.50 (vs NT$0.67 in 1Q 2020)

Price target increased to NT$50.38

Is Macronix International Co., Ltd. (TPE:2337) The Right Choice For A Smart Dividend Investor?

Does Macronix International (TPE:2337) Have A Healthy Balance Sheet?

Will Macronix International's (TPE:2337) Growth In ROCE Persist?